Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2026)
Capricor Therapeutics' (CAPR) quarterly Times Interest Earned came in at -$59.82 in Q1 2026, up 45.59% year-on-year from -$41.09 in Q1 2025, and down 382.04% quarter-over-quarter from -$12.41 in Q4 2025.
Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2026) Analysis & Trends
Capricor Therapeutics' Times Interest Earned history runs 14 years deep, the most recent figure standing at -$59.82 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 45.59% year-over-year to -$59.82 in Q1 2026; TTM through Mar 2026 was -$35.09, a 57.67% increase from a year earlier, with the FY2025 full-year figure at -$0.39, up 7.03% from the prior year.
- Times Interest Earned fell to -$59.82 in Q1 2026 per CAPR's latest filing, from -$12.41 in the prior quarter.
- Across five years, Times Interest Earned topped out at $26.37 in Q4 2022 and bottomed at -$254.82 in Q1 2023.
- The 5-year median for Times Interest Earned is -$1.67 (2022), against an average of -$32.34.
- Across the five-year window, Times Interest Earned jumped 99.87% in 2024 and tumbled 33136.24% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $26.37 in 2022, then slumped by 123.69% to -$6.25 in 2023, then tumbled by 443.34% to -$33.95 in 2024, then surged by 63.45% to -$12.41 in 2025, then plunged by 382.04% to -$59.82 in 2026.
- Per Business Quant, the three latest CAPR Times Interest Earned figures stand at -$59.82 (Q1 2026), -$12.41 (Q4 2025), and -$0.79 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Capricor Therapeutics | 1.12 Bn | 1.12 Bn | - | -59.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.82 |
| Dec 31, 2025 | -12.41 |
| Sep 30, 2025 | -0.79 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -109.96 |
| Dec 31, 2024 | -33.95 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.33 |
| Dec 31, 2023 | -6.25 |
| Sep 30, 2023 | -1.86 |
| Jun 30, 2023 | -0.66 |
| Mar 31, 2023 | -254.82 |
| Dec 31, 2022 | 26.37 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -1.67 |
| Mar 31, 2022 | -91.76 |
| Dec 31, 2021 | 48.31 |
| Sep 30, 2021 | -0.75 |
| Sep 30, 2020 | -0.48 |